Huaqiang Zhu

发表

Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122

Rui Li, Jun Lu, Xian Jiang, 2016, Journal of Cancer Research and Clinical Oncology.

MiR-492 is functionally involved in Oxaliplatin resistance in colon cancer cells LS174T via its regulating the expression of CD147

Leping Li, Hua-qiang Zhu, Honglai Zhang, 2015, Molecular and Cellular Biochemistry.

Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses.

Jun Lu, Hua-qiang Zhu, Xu Zhou, 2014, International journal of clinical and experimental medicine.

Potential prognosis index for m6A-related mRNA in cholangiocarcinoma

Jun Lu, Jianlu Wang, Hua-qiang Zhu, 2022, BMC Cancer.

CCAT1 promotes hepatocellular carcinoma cell proliferation and invasion.

Xu Zhou, Jun Lu, Hua-qiang Zhu, 2015, International journal of clinical and experimental pathology.

Aberrant Expression of CCAT1 Regulated by c-Myc Predicts the Prognosis of Hepatocellular Carcinoma.

Jun Lu, Hua-qiang Zhu, Hong Chang, 2015, Asian Pacific journal of cancer prevention : APJCP.

Aberrant Expression of CCAT 1 Regulated by c-Myc Predicts the Prognosis of Hepatocellular Carcinoma

Xu Zhou, Jun Lu, Hua-qiang Zhu, 2015 .

Analysis of circular RNA-associated competing endogenous RNA network in breast cancer

Xu Zhou, Minshan Chen, Jun Lu, 2019, Oncology letters.

Bilirubin protects grafts against nonspecific inflammation-induced injury in syngeneic intraportal islet transplantation

Xueying Sun, Shangha Pan, Hua-qiang Zhu, 2010, Experimental & Molecular Medicine.

MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene

Jun Lu, Jianlu Wang, Hua-qiang Zhu, 2022, Journal of hepatocellular carcinoma.

Radiofrequency ablation for hepatic hemangiomas: A consensus from a Chinese panel of experts

K. Ma, J. Ji, Jiayin Yang, 2017, World journal of gastroenterology.

Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo.

Jun Lu, Hua-qiang Zhu, Hong Chang, 2016, Oncology reports.

2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.

Jie Li, Xian Jiang, Xueying Sun, 2014, Cancer letters.

Association between gut microbiota and hepatocellular carcinoma and biliary tract cancer: A mendelian randomization study

Xu Zhou, Xie Song, Huaqiang Zhu, 2024, World journal of clinical cases.